Beta-blockers for heart failure
47 results
1 - 47
Beta‐blockers for congestive heart failure in children- Beta‐blockers in patients without heart failure after myocardial infarction
- Beta‐blockers and inhibitors of the renin‐angiotensin aldosterone system for chronic heart failure with preserved ejection fraction
- Nurse‐led titration of angiotensin converting enzyme inhibitors, beta‐adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction
- Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity
- Beta‐blockers for hypertension
- Cardioselective beta‐blockers for chronic obstructive pulmonary disease
- Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing cardiac surgery
- First‐line diuretics versus other classes of antihypertensive drugs for hypertension
- Beta‐adrenergic blockers for perioperative cardiac risk reduction in people undergoing vascular surgery
- Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity in adults undergoing non‐cardiac surgery
- Beta‐blockers for preventing aortic dissection in Marfan syndrome
- Cardioselective beta‐blockers for reversible airway disease
- Calcium channel blockers versus other classes of drugs for hypertension
- First‐line drugs inhibiting the renin angiotensin system versus other first‐line antihypertensive drug classes for hypertension
- Digitalis for treatment of heart failure in patients in sinus rhythm
- Phosphodiesterase III inhibitors for heart failure
- Pharmacological agents for preventing morbidity associated with the haemodynamic response to tracheal intubation
- Pharmacological interventions for heart failure in people with chronic kidney disease
- Diuretics for heart failure: Cochrane systematic review
- Pharmacotherapy for hypertension in adults aged 18 to 59 years
- Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals